相关实验视频
Updated: May 5, 2026
![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)
Solid-phase Synthesis of [4.4] Spirocyclic Oximes
Published on: February 6, 2019
作为抗增殖剂的新型类固醇氧化物:设计,合成和生物活性评估
Ana R Gomes1, Elisiário J Tavares-da-Silva2, Ana M Abrantes3
1Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), Biophysics Institute of Faculty of Medicine, Azinhaga de Santa Comba, Pólo III - Pólo das Ciências da Saúde 3000-548 Coimbra, Portugal; Univ Coimbra, CERES, Faculty of Pharmacy, Laboratory of Pharmaceutical Chemistry, Azinhaga de Santa Comba, Pólo III - Pólo das Ciências da Saúde 3000-548 Coimbra, Portugal.
合成了新的类固醇氧化物,并对前列腺癌,肺癌和乳腺癌进行了测试. 化合物EP2OX表现出显著的抗癌活性,可能是潜在的候选药物.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
背景情况:
- 氧化物和类固醇具有抗癌性质.
- 结合这些支架可以产生新的抗癌剂.
- 类固醇对药物开发有价值,因为它们的特性和可修改性.
研究的目的:
- 设计和合成新的类固醇氧化物.
- 评估它们对前列腺癌,肺癌和三阴性乳腺癌细胞系的抗癌活性.
- 为了评估选择性和血红相容性.
主要方法:
- 类固醇氧化物的合成 (OX1,OX2,OX3,OX3.1,OX4,EP2OX,FormOX,ExeOX).
- 使用PC3,H1299和HCC1806癌细胞系进行抗癌活性评估.
- 对MRC-5正常细胞系和血红相容性测试的选择性评估.
主要成果:
- EP2OX对测试的癌细胞显示出最高的强度 (IC50: 1.133.70 μM),其次是OX1 (IC50: 18.6929.95 μM).
- EP2OX通过ROS和亡/亡诱导的DNA损伤;OX1诱导的亡.
- 这两种化合物都表现出癌细胞选择性,并且是非溶血的.
结论:
- 类固醇氧化物在瘤学中很重要.
- 新型化合物EP2OX是开发新癌症疗法的有希望的起点.
- 需要进一步研究EP2OX用于治疗前列腺癌,肺癌和三阴性乳腺癌.
相关概念视频
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Viral Protein Synthesis
Antifungal Agents

